There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

Cold and the flu season will soon be on our doorsteps. Therefore, it is better to be prepared with a flu shot ideally ...

A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

The former public health official who filed a whistleblower complaint against the Trump administration is ringing the alarm ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Onconova Therapeutics Inc ( (TRAW) ) has released its Q3 earnings. Here is a breakdown of the information Onconova Therapeutics Inc presented ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

They found that over 70 percent of people with mild or moderate cases of COVID-19 carried certain autoantibodies in their ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...